cancer, 86
breast, 73
ovarian, 35
ovarian cancer, 31
breast cancer, 30
and, 18
VHL, 16
DM, 15
disease, 12
cell, 12
renal, 11
BRCA1, 10
carcinomas, 10
of, 10
cancers, 10
deficiency, 10
HD, 9
tumours, 8
syndrome, 8
C7, 8
sporadic, 8
WAS, 8
CHD, 8
IDDM, 7
ataxia-telangiectasia, 7
von, 7
dystrophy, 7
carcinoma, 7
bone, 6
Prostate, 6
RB1, 6
aniridia, 6
HPRT, 6
hereditary, 6
DTD, 6
dysplasia, 6
ATM, 6
hereditary breast, 6
breast / ovarian cancer, 5
AO2, 5
HPT, 5
renal cell carcinomas, 5
JT, 5
A-T, 5
mutations, 5
breast and ovarian cancer, 5
Myotonic dystrophy, 5
Classical, 5
C6, 5
von Hippel-Lindau, 5
familial, 5
Hippel-Lindau, 5
myotonia, 5
Atm, 5
SJS, 5
bone dysplasia, 5
papillary, 4
renal cell carcinoma, 4
Myotonic, 4
galactosemia, 4
C9, 4
breast and / or ovarian cancer, 4
PTEN, 4
IDDM2, 4
adenocarcinoma, 4
tumor, 4
vWF, 4
HPT-JT, 3
the, 3
Huntington, 3
von Hippel-Lindau disease, 3
Duarte, 3
RCC, 3
type, 3
renal hamartomas, 3
tumors, 3
Lesch-Nyhan, 3
Huntington disease, 3
APRT, 3
huntingtin, 3
Santamaria, 3
Lesch-Nyhan syndrome, 3
AT, 3
PKU, 3
endometrial, 3
breast / ovarian, 3
colorectal cancer, 3
non-papillary, 3
breast and, 3
colorectal cancers, 3
kidney, 2
pancreatic, 2
breast cancers, 2
breast carcinomas, 2
lipomas, 2
human, 2
inherited, 2
tumour, 2
IID von Willebrand disease, 2
mutation, 2
lymphomas, 2
WASP, 2
Li-Fraumeni syndrome, 2
breast carcinoma, 2
thrombocytopenia, 2
FED, 2
chondrodysplasias, 2
coli, 2
human breast cancer, 2
Wiskott-Aldrich, 2
heart, 2
prostate carcinomas, 2
adult, 2
adenomatous, 2
locus, 2
Willebrand, 2
IID, 2
polyposis, 2
prostatic, 2
chromophobe, 2
myotonic, 2
AAPC, 2
von Willebrand disease, 2
colorectal, 2
disease-associated, 2
PWS, 2
Li-Fraumeni, 2
FAP, 2
von Willebrand, 2
sporadic breast and ovarian, 1
hereditary breast cancers, 1
first, 1
endometrial carcinomas, 1
coronary heart disease, 1
mismatched, 1
cerebellar ataxia, 1
tumorigenesis, 1
attenuated, 1
fibrosis, 1
thymomas, 1
retinal , cerebellar and spinal haemangioblastomas, 1
hypertrophic cardiomyopathy, 1
attenuated adenomatous polyposis coli, 1
Norrie disease ( ND, 1
male-infertility, 1
G6PD deficient, 1
young onset breast cancer and ovarian cancer, 1
deficiency of C9, 1
HPRT-deficient, 1
infertile, 1
leukocyte, 1
breast-ovarian, 1
familial breast and ovarian cancer, 1
nonpolyposis colorectal cancer ( HNPCC, 1
renal cell tumours, 1
class, 1
diastrophic dysplasia, 1
Krabbe, 1
Prader-Willi, 1
spinal, 1
phaeochromocytoma, 1
C9 deficiency, 1
endometrial carcinoma, 1
retinal, 1
pancreatic cancer, 1
phosphoribosyl-transferase ( HPRT ) deficiency, 1
Myotonic dystrophy ( DM, 1
breast and ovarian, 1
Alu, 1
thymic lymphomas, 1
short stature, 1
haploinsufficiency, 1
heritable, 1
skeletal myopathy, 1
growth-retarded, 1
metastatic tumors, 1
deficiency of C6 and C7, 1
GALT, 1
male, 1
Familial, 1
fibre-type dependent atrophy, 1
nonocular tumors, 1
X-linked thrombocytopenia, 1
glioblastomas, 1
short, 1
retinoblastoma, 1
cancer-associated diseases, 1
AKU, 1
diabetes, 1
C7 deficiency, 1
sporadic renal cell carcinoma, 1
ND, 1
Prader-Willi syndrome ( PWS, 1
adult onset globoid cell leukodystrophy, 1
hereditary cancer, 1
kidney allografts, 1
classic Li-Fraumeni syndrome, 1
Emery-Dreifuss, 1
dystrophia, 1
gene, 1
adult renal hamartomas, 1
bilateral, 1
breast and ovarian cancers, 1
hereditary adult neuromuscular disease, 1
tumourigenesis, 1
polycystic kidney disease, 1
Wiskott-Aldrich syndrome protein, 1
early-onset breast and / or ovarian cancer, 1
prostate, 1
phosphoribosyl-transferase, 1
AO-GLD, 1
onset, 1
Krabbe disease, 1
disease ( HD, 1
Familial adenomatous polyposis, 1
hypoxanthine-guanine, 1
breast cancer and ovarian cancer, 1
cerebellar, 1
sporadic aniridia, 1
Wiskott-Aldrich syndrome, 1
muscular, 1
alkaptonuria, 1
mellitus, 1
cardiomyopathy, 1
oncocytomas, 1
globoid cell leukodystrophy, 1
leiomyosarcoma, 1
neuromuscular, 1
chondrodystrophic myotonia, 1
haemangioblastomas, 1
breast or ovarian cancer, 1
retinoblastoma gene, 1
paraplegia, 1
renal oncocytomas, 1
parenchymal, 1
cystic kidney disease, 1
atelosteogenesis type 2, 1
leukodystrophy, 1
III, 1
AO, 1
atelosteogenesis type 2 ( AO2, 1
Norrie disease, 1
autosomal dominant disease, 1
Hereditary hyperparathyroidism-jaw tumor syndrome, 1
defective, 1
Hippel-Lindau tumor, 1
phenylketonuria, 1
Norrie, 1
diastrophic dysplasia ( DTD, 1
breast / ovarian tumorigenesis, 1
CETP, 1
X-linked, 1
estrogen receptor-positive, 1
male breast cancer, 1
polymorphism, 1
tumour of the proband, 1
globoid, 1
hypoxanthine-guanine phosphoribosyl-transferase, 1
renal cell carcinoma and phaeochromocytoma, 1
parenchymal tumours, 1
nonpolyposis, 1
Meiosis, 1
Prostate cancer, 1
hereditary retinoblastoma, 1
renal lesions, 1
prostate carcinoma, 1
premature protein termination, 1
clear-cell, 1
hypertrophic, 1
allografts, 1
familial breast and ovarian, 1
haemangioblastoma, 1
fish-eye, 1
myotonica, 1
progressive skeletal myopathy, 1
prostatic adenocarcinoma, 1
Complete, 1
human breast carcinomas, 1
cataract, 1
achondrogenesis type 1B, 1
coronary, 1
pancreatic cancers, 1
clear-cell renal cell carcinoma, 1
fish-eye disease, 1
1, 1
hyperparathyroidism-jaw tumor syndrome, 1
kinases, 1
Schwartz-Jampel syndrome, 1
metastasis, 1
prostate adenocarcinoma, 1
dystrophia myotonica, 1
thymic, 1
enzyme deficiency, 1
Escherichia coli, 1
synergistic, 1
diabetes mellitus, 1
enzyme, 1
human tumours, 1
Aspergillus, 1
RCC- and von Hippel-Lindau disease-associated tumors, 1
Prader-Willi syndrome, 1
bilateral sporadic aniridia, 1
meiotic failure, 1
breast and / or ovarian, 1
hypoxanthine-guanine phosphoribosyl-transferase ( HPRT ) deficiency, 1
